These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8993443

  • 1. Phospholipase C activation by VIP1 and VIP2 receptors expressed in COS 7 cells involves a pertussis toxin-sensitive mechanism.
    MacKenzie CJ, Lutz EM, McCulloch DA, Mitchell R, Harmar AJ.
    Ann N Y Acad Sci; 1996 Dec 26; 805():579-84. PubMed ID: 8993443
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor.
    MacKenzie CJ, Lutz EM, Johnson MS, Robertson DN, Holland PJ, Mitchell R.
    Endocrinology; 2001 Mar 26; 142(3):1209-17. PubMed ID: 11181537
    [Abstract] [Full Text] [Related]

  • 3. The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.
    Van Rampelbergh J, Poloczek P, Françoys I, Delporte C, Winand J, Robberecht P, Waelbroeck M.
    Biochim Biophys Acta; 1997 Jun 27; 1357(2):249-55. PubMed ID: 9223629
    [Abstract] [Full Text] [Related]

  • 4. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs.
    Dickinson T, Fleetwood-Walker SM, Mitchell R, Lutz EM.
    Neuropeptides; 1997 Apr 27; 31(2):175-85. PubMed ID: 9179871
    [Abstract] [Full Text] [Related]

  • 5. Chimaeric VIP2/PACAP receptors reveal that agonist pharmacology but not signal transduction is determined by extracellular domain 1.
    Lutz EM, MacKenzie CJ, Morrow J, Mitchell R, Bennie J, Carroll S, Clark E, Harmar AJ.
    Ann N Y Acad Sci; 1996 Dec 26; 805():574-8. PubMed ID: 8993442
    [No Abstract] [Full Text] [Related]

  • 6. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.
    Gourlet P, Vertongen P, Vandermeers A, Vandermeers-Piret MC, Rathe J, De Neef P, Waelbroeck M, Robberecht P.
    Peptides; 1997 Dec 26; 18(3):403-8. PubMed ID: 9145428
    [Abstract] [Full Text] [Related]

  • 7. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
    Jiang X, Wang HY, Yu J, Ganea D.
    Ann N Y Acad Sci; 1998 Dec 11; 865():397-407. PubMed ID: 9928038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
    Gourlet P, Vandermeers A, Van Rampelbergh J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P.
    Ann N Y Acad Sci; 1998 Dec 11; 865():247-52. PubMed ID: 9928018
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of VIP1/PACAP receptors in postoperative ileus in rats.
    De Winter BY, Robberecht P, Boeckxstaens GE, De Man JG, Moreels TG, Herman AG, Pelckmans PA.
    Br J Pharmacol; 1998 Jul 11; 124(6):1181-6. PubMed ID: 9720789
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1996 Dec 11; 50(6):1596-604. PubMed ID: 8967982
    [Abstract] [Full Text] [Related]

  • 16. ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.
    McCulloch DA, Lutz EM, Johnson MS, Robertson DN, MacKenzie CJ, Holland PJ, Mitchell R.
    Mol Pharmacol; 2001 Jun 11; 59(6):1523-32. PubMed ID: 11353814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D, Delgado M, Martinez C, Gomariz RP, Guerrero JM, Calvo JR.
    Biochim Biophys Acta; 1997 Dec 12; 1359(3):250-62. PubMed ID: 9434131
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.